IDH1 and glioma: In accordance with this preclinical data, analysis of surgically resected tumors from patients with IDH1-mutant gliomas indicate decreased levels of 2-HG following pretreatment with either AG-881 or AG-120, indicating that both inhibitors penetrate into the CNS (ClinicalTrials.gov NCT03343197) [78].